(Q44667120)

5 December 2017

Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy (English)

1 reference

5 December 2017

0 references

1 reference

1

Douglas S Hawkins

1 reference

5 December 2017

Carola A S Arndt

2

1 reference

PubMed ID

14635080

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

1 reference

5 December 2017

98

1 reference

5 December 2017

2447-2456

1 reference

5 December 2017

11

1 reference

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

5 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.11799

1 reference

7 January 2021

Multiple pulmonary resections in the treatment of osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Improved survival in children with osteosarcoma following resection of pulmonary metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Results of thoracotomy in osteogenic sarcoma with pulmonary metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

The contribution of salvage surgery to the management of childhood osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Metastasectomy for sarcomatous pediatric histologies: results and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

The effect of local recurrence on survival in resected osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Prognostic factors and imaging patterns of recurrent pulmonary nodules after thoracotomy in children with osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese Musculoskeletal Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11799

7 January 2021

Identifiers

DOI

10.1002/CNCR.11799

1 reference

5 December 2017

1 reference

PubMed ID

14635080